Physician

Paul R Sieber, M.D.

According to 2025 Medicare claims, Paul Sieber, M.D. (NPI: 1851375026) practices urology in the Lancaster, PA market, with the plurality of this provider's patient population coming from Lancaster, PA. This provider's primary affiliated billing organization is THE CENTERS FOR ADVANCED UROLOGY, LLP (NPI: 1295565356; TIN: 474352018) and primary practice location at 17604-3200. Sieber is affiliated with the Lancaster General Health Community Care Collaborative, LLC (ACO ID: A2019), participating under the MSSP model.

Sieber's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 782 traditional Medicare patients, billed 19,831 HCPCS/CPT codes, and received $1,247,114 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,619 prescription claims across 609 beneficiaries totaling $7,505,106 in drug costs, led by Xtandi (Enzalutamide). DME data shows 114 claims. Open Payments data shows 377 records totaling $2,519,327. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $916,762 and ending at $1,247,114. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,247,433 to $7,505,106. In contrast, DME billing represents a smaller volume and declined steadily, from $1,333 to $854.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,094	15,929	$916,762
2016	1,101	22,661	$1,557,276
2017	1,081	28,422	$1,170,548
2018	1,042	23,386	$1,551,077
2019	1,000	24,560	$1,111,393
2020	891	29,763	$977,096
2021	962	24,771	$913,755
2022	994	26,446	$1,894,990
2023	1,073	24,884	$1,676,163
2024	782	19,831	$1,247,114

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	516	2,659	$1,247,433
2016	542	2,640	$1,371,493
2017	560	2,457	$1,487,431
2018	521	2,291	$2,253,093
2019	542	2,436	$2,801,651
2020	564	2,689	$4,219,625
2021	584	2,761	$5,368,141
2022	607	2,905	$5,274,019
2023	667	3,244	$5,526,731
2024	609	3,619	$7,505,106

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	11	246	$48,862
2016	14	183	$50,843
2017	58	251	$55,712
2018	41	251	$64,012
2019	40	286	$65,811
2020	62	275	$70,182
2021	39	288	$84,991
2022	100	297	$85,187
2023	28	152	$90,834
2024	N/R	114	$65,726

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	400	795	$83
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	339	379	$58
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	416	730	$12
81001	Manual urinalysis test with examination using microscope, automated	239	278	$3
81003	Automated urinalysis test	261	315	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	194	5,940	$2,499,696
Nubeqa	Darolutamide	107	3,180	$1,297,699
Orgovyx	Relugolix	389	11,670	$1,006,915
Lynparza	Olaparib	55	1,650	$787,619
Erleada	Apalutamide	52	1,560	$738,126

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	N/R	52	$56,341
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	22	$8,532
A4332	Lubricant, individual sterile packet, each	N	N/R	40	$854

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	183	$118,776	Astellas Pharma US Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	194	$2,400,551	PFIZER INC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Paul R. Sieber, M.D.?

Tedicare shows public-source Medicare data for Paul R. Sieber, M.D. (NPI 1851375026), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Paul R. Sieber, M.D. have ACO affiliation data?

Paul R. Sieber, M.D. is shown with ACO affiliation data for Lancaster General Health Community Care Collaborative, LLC (MSSP, ACO ID A2019).

What billing organization is linked to Paul R. Sieber, M.D.?

Paul R. Sieber, M.D. is linked to THE CENTERS FOR ADVANCED UROLOGY, LLP (billing NPI 1295565356) in the available physician profile data.

Does Paul R. Sieber, M.D. have Open Payments data?

Paul R. Sieber, M.D. has 377 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.